Inventor · disambiguated record
Wim Van Schooten
Also filed as: VAN SCHOOTEN WIM
18 granted patents·22 pending applications·199 citations·filing 2001–2025
93Inventor score
Top patents by PatentIndex Score
40 records- 0194US11186639B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Granted Nov 30, 2021·7 cites·20 claims
- 0293US11421027B2CD3 binding antibodiesTENEOONE INC·Filed 2021·Granted Aug 23, 2022·6 cites·17 claims
- 0393US11390681B2Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOTWO INC·Filed 2021·Granted Jul 19, 2022·8 cites·20 claims
- 0493US7129084B2Production of humanized antibodies in transgenic animalsTHERAPEUTIC HUMAN POLYCLONALS·Filed 2001·Granted Oct 31, 2006·112 cites·18 claims
- 0592US11505606B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Nov 22, 2022·10 cites·30 claims
- 0691US7585668B2Humanized immunoglobulin lociTHERAPEUTIC HUMAN POLYCLONALS·Filed 2004·Granted Sep 8, 2009·38 cites·3 claims
- 0786US11613572B2CD3 binding antibodiesTENEOBIO INC·Filed 2017·Granted Mar 28, 2023·4 cites·13 claims
- 0886US11434299B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2017·Granted Sep 6, 2022·4 cites·17 claims
- 0985US11427642B2Anti-BCMA heavy chain-only antibodiesTENEOONE INC·Filed 2018·Granted Aug 30, 2022·4 cites·13 claims
- 1083US8652842B2Humanized immunoglobulin lociTHERAPEUTIC HUMAN POLYCLONALS·Filed 2013·Granted Feb 18, 2014·3 cites·3 claims
- 1183US2025066476A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2023·Application pending·0 cites
- 1279US8410333B2Humanized immunoglobulin lociBUELOW ROLAND·Filed 2009·Granted Apr 2, 2013·3 cites·2 claims
- 1379US2023272075A1Cd3 binding antibodiesTENEOBIO INC·Filed 2022·Application pending·0 cites
- 1477US2025340638A1Cd3 binding antibodiesTENEOONE INC·Filed 2025·Application pending·0 cites
- 1577US2024117050A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 1677US2023082151A1Cd3 binding antibodiesTENEOONE INC·Filed 2022·Application pending·0 cites
- 1776US12371505B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2022·Granted Jul 29, 2025·0 cites·10 claims
- 1874US2025236681A1Heavy chain antibodies binding to psmaTENEOBIO INC·Filed 2024·Application pending·0 cites
- 1974US2022332820A1Multispecific heavy chain antibodies with modified heavy chain constant regionsTENEOONE INC·Filed 2021·Application pending·0 cites
- 2071US2024124599A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2168US2023242668A1Heavy chain antibodies binding to psmaTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2268US2024018235A1Cd3 binding antibodiesTENEOBIO INC·Filed 2023·Application pending·0 cites
- 2367US2024117046A1Heavy chain antibodies binding to cd22TENEOBIO INC·Filed 2023·Application pending·0 cites
- 2467US2025179180A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2565US2025270337A1Anti-bcma heavy chain-only antibodiesTENEOBIO INC·Filed 2025·Application pending·0 cites
- 2665US2023060847A1Anti-bcma heavy chain-only antibodiesTENEOONE INC·Filed 2022·Application pending·0 cites
- 2765US2020339685A1Cd3-delta/epsilon heterodimer specific antibodiesTENEOBIO INC·Filed 2018·Application pending·0 cites
- 2862US12180298B2Heavy chain antibodies binding to PSMATENEOBIO INC·Filed 2020·Granted Dec 31, 2024·0 cites·28 claims
- 2960US12202898B2Heavy chain antibodies binding to CD19TENEOTWO INC·Filed 2019·Granted Jan 21, 2025·0 cites·39 claims
- 3059US11970540B2Anti-BCMA heavy chain-only antibodiesTENEOBIO INC·Filed 2018·Granted Apr 30, 2024·0 cites·14 claims
- 3157US11873336B2Heavy chain antibodies binding to CD22TENEOBIO INC·Filed 2018·Granted Jan 16, 2024·0 cites·14 claims
- 3257USRE47131EHumanized immunoglobulin lociTHERAPEUTIC HUMAN POLYCLONALS INC·Filed 2016·Granted Nov 20, 2018·0 cites·3 claims
- 3352US2005153392A1Transgenesis with humanized immunoglobulin lociFiled 2004·Application pending·0 cites
- 3451US12495776B2Transgenic non-human animals producing modified heavy chain-only antibodiesTENEOBIO INC·Filed 2017·Granted Dec 16, 2025·0 cites·14 claims
- 3550US2020138865A1Anti-b-cell maturation antigen chimeric antigen receptors with human domainsUS HEALTH·Filed 2018·Application pending·0 cites
- 3650US2004158880A1Suppression of endogenous immunoglobulin expression in transgenic non-human animals expressing humanized or human antibodiesFiled 2004·Application pending·0 cites
- 3747US2022372162A1Pct/us2020/066088TENEOFOUR INC·Filed 2020·Application pending·0 cites
- 3845US2021388106A1Heavy chain antibodies binding to cd38TENEOBIO INC·Filed 2019·Application pending·0 cites
- 3941US2020207867A1Heavy chain antibodies binding to ectoenzymesTENEOBIO INC·Filed 2018·Application pending·0 cites
- 4039US2014056897A1Bispecific three-chain antibody-like moleculesBUELOW ROLAND·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Wim Van Schooten files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →